gastro intestinal stromal tumour

How research changes outcomes for men with GI cancers

Gastro-intestinal cancers are cancers that affect the digestive system. Some GI cancers disproportionately affect men, especially stomach, liver, and oesophageal cancer.

These cancers are devastating, but research is making a difference. The overall five-year survival rates for stomach, liver, and oesophageal cancer have each risen by about 10% since the mid-1980s. By raising awareness of these cancers and the desperate need for better treatment, you can make an impact for patients in the future.

Causes and risk factors

Although there are many unanswered questions about GI cancers, there are some known causes and risk factors. You can find out more about the causes and risk factors of each cancer here:

Oesophageal Cancer

Gastro-Intestinal Stromal Tumour (GIST)

Liver Cancer

Neuroendocrine Tumours (NETs)

Stomach Cancer

Colorectal Cancer

Gallbladder & Biliary Tract Cancer

Small Bowel Cancer

Pancreatic Cancer

Anal Cancer

 

Clinical trials and research

Conducting research and clinical trials is essential to creating life-saving new treatments for patients with GI cancers. The GI Cancer Institute has developed research priorities which define the key areas where research is most needed.

Clinical research does not just benefit patients in the future. It allows patients now to have immediate access to the latest treatments and a high standard of care. You can find out more about how our clinical trials and research give patients more options by clicking here.

The GI Cancer Institute is a not-for-profit research organisation and community support is a fundamental part of our work. Read about how people affected by GI cancers are fighting to make a difference in honour of their loved ones:

 

 

 

 

Nadia De Giuseppe

 

 

 

 

 

Ross Hinscliff

 

 

 

Daniel & Oliver Simpson

trine daniel and oliver simpson

 

Find out more about getting involved with the GI Cancer Institute here.

 

 

Share